Skip to content
Yog Pharma
Pain and inflammationNSAID (propionic acid derivative)

Naproxen Sodium is an NSAID (propionic acid derivative) indicated for pain, arthritis, dysmenorrhea and fever. We supply it to US manufacturers of tablets and capsules.

CAS26159-34-2252.2 g/molC14H13NaO3
2D structure of Naproxen Sodium, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 23681059) and FDA’s substance registry

CAS number

26159-34-2

Molecular formula

C14H13NaO3

Molecular weight

252.2g/mol

FDA UNII

IUPAC name

sodium (2S)-2-(6-methoxynaphthalen-2-yl)propanoate

InChIKey

CDBRNDSHEYLDJV-FVGYRXGTSA-M

Appearance
White to creamy crystalline powder.
Solubility
Soluble in water and methanol, sparingly soluble in alcohol, and practically insoluble in chloroform and toluene.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Strengths are labeled two ways. OTC 220 mg tablets are stated as the sodium salt, and prescription tablets as naproxen: 275 mg of the salt delivers 250 mg.

On the US market

Reference product
AnaproxNDA 018164
Approved ANDAs
18 with a marketed product
Approved forms and strengths
  • Tablet 220 mg, 250 mg, 500 mg
  • Extended-release tablet 375 mg, 500 mg, 750 mg
  • Capsule 200 mg

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com